{
  "docId": "019de070-da34-70fa-b6ea-612c42635c34",
  "docSlug": "1519080da03b1584f82c21fb8b213d00",
  "documentTitle": "Alkermes | Results Presentation Deck | 13 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 13,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 18,
  "notes": "Includes a blue highlight box around the Q1'21 column.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-da34-70fa-b6ea-612c42635c34/5",
  "deckHref": "/decks/019de070-da34-70fa-b6ea-612c42635c34",
  "deckJsonHref": "/decks/019de070-da34-70fa-b6ea-612c42635c34.json",
  "deckAnchorHref": "/decks/019de070-da34-70fa-b6ea-612c42635c34#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.58,
        "x": 0.122,
        "y": 0.85
      },
      "kind": "source-note",
      "text": "*Decrease in VIVITROL net sales in Q1'21 was primarily due to COVID-19 pandemic-related disruptions. ** Inclusive of ARISTADA INITIO. Amounts in the table above do not sum due to rounding.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "881920fc-005b-411a-b554-c89bd283ec96",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.605,
        "w": 0.756,
        "x": 0.122,
        "y": 0.228
      },
      "kind": "table",
      "text": "VIVITROL $74.5* $78.8 (5%)* ARISTADA $55.4 $51.0 9% Manufacturing & Royalty Revenue $119.8 $116.3 3% License Revenue $1.5 - N/A Research & Development Revenue $0.1 $0.2 N/A Total Revenue $251.4 $246.2 2%",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "32b937af-1b59-45af-b97a-f6247fcc0964",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.435,
        "x": 0.056,
        "y": 0.125
      },
      "kind": "title",
      "text": "First Quarter 2021 Revenue Summary",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "880ab678-e686-4d48-b463-966d710be6e7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "cf19ba77-8b15-4cdf-af7d-61eb4a85d2ad",
      "evidence": "table/data: VIVITROL $74.5* $78.8 (5%)* ARISTADA $55.4 $51.0 9% Manufacturing & Royalty Revenue $119.8 $116.3 3% License Revenue $1.5 - N/A Research & Development Revenue $0.1 $0.2 N/A Total Revenue $251.4 $246.2 2%",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 4,
      "beatId": "ad4e861e-6017-4066-8b81-4e114615935b",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Financials",
      "beatSlug": "sequoia-pitch-financials",
      "evidence": "Slides 4-6 provide a summary of Q1 2021 financial results",
      "position": 0,
      "confidence": 0.7,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}